Sprycel 70mg (Dasatinib) x 60 Tablets
Product Description
Sprycel (Dasatinib) 70mg is an innovative medication designed for the treatment of specific types of blood cancers, including chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL). Each bottle contains 60 tablets, providing a convenient supply for ongoing treatment.
Key Features
- Contains 70mg of Dasatinib per tablet.
- Formulated to target cancer cells effectively.
- Available in a bottle of 60 tablets for extended use.
- Approved for patients with resistant forms of leukemia.
How It Works
Dasatinib is a tyrosine kinase inhibitor that works by blocking the signals that tell cancer cells to grow and divide. By inhibiting these signals, Sprycel helps to control the progression of the disease and improve patient outcomes.
Usage Instructions
Patients should take Sprycel as prescribed by their healthcare provider. It is typically taken once daily with or without food. It is important to follow the prescribed dosage and not to exceed the recommended amount.
Possible Side Effects
Common side effects may include fatigue, headache, nausea, and diarrhea. Serious side effects can occur, so it is essential to communicate any unusual symptoms to a healthcare professional promptly.
Consultation
Before starting treatment with Sprycel, patients should discuss their complete medical history and any other medications they are taking with their healthcare provider to avoid potential interactions and complications.
Storage Instructions
Store Sprycel at room temperature, away from moisture and heat. Keep out of reach of children and pets.
Conclusion
Sprycel 70mg (Dasatinib) is a vital medication for managing certain types of leukemia, providing patients with an effective option for treatment. Always consult with a healthcare professional for personalized medical advice and treatment plans.
